Publications

This collaboration with the Broad Institute presented at the American Society for Mass Spectrometry describes a Proteograph™ application for cardiovascular biomarker research using deep plasma proteomics. Over 2000 proteins were detected in each individual patient sample with a total of over 4000 across 16 samples.

This Nature Communications paper demonstrates that Proteograph technology is unmatched in its combination of depth, breadth, and speed—creating the necessary scale for proteomics profiling studies that lead to unprecedented discovery.

DOI: 10.1038/s41467-020-17033-7
Pubmed: 32699280

This poster presented at the American Society for Mass Spectrometry from Oregon Health Sciences University describes a Proteograph™ application proof-of-concept pilot study on 32 prostate cancer serum specimens retrospectively collected from patients with high and low tumor grades.

This AACR 2020 poster demonstrates how Seer's proprietary nanoparticle technology can be optimized for unbiased, deep plasma proteome profiling.